Miclxin is a potent inhibitor of mutant β-catenin involved in the Wnt signaling pathway; it induces β-catenin-dependent apoptosis leading to mitochondrial damage and loss of mitochondrial membrane potential; it exerts antitumor effects by targeting MIC60, a core component of the mitochondrial contact site and cristae organizing system (MICOS) complex.